Current Issue
Volume 1: Issue 4 - August 2018
What Will Be the Psychotropic Drugs of Tomorrow?
*Corresponding author: Michel Bourin, Neurobiology of Mood Disorders,University of Nantes, 98 rue Joseph Blanchart, Nantes, France, Tel: 33610858103 E-mail: michel.bourin@univ-nantes.fr
Pdf Full textNTPDase2 as a Surface Marker to Isolate Flow Cytometrically a Müller Glial Cell Enriched Population from Dissociated Neural Retinae
*Corresponding author: Jan Wijnholds, Department of Ophthalmology,Leiden University Medical Center, 2300 RC, Leiden, The Netherlands, E-mail: J.Wijnholds@lumc.nl
Pdf Full textThe Contribution of Aluminium to Alzheimer’s disease: A Neuropathological Investigation of Renal Dialysis Cases
*Corresponding author: Christopher M Morris, Medical Toxicology Centre, Newcastle University, Wolfson Building, Claremont Place, Newcastle upon Tyne NE2 4AA, UK, E-mail: c.m.morris@ncl.ac.uk
Pdf Full textExploring a Neuroscientific Perspective of Travel Benefits and Decision-Making
*Corresponding author: Betsy Ng, Research Scientist, National Institute of Education, Nanyang Technological University, Singapore, E-mail: betsy.ng@nie.edu.sg
Pdf Full textVestibular Evoked Myogenic Potentials Might Differentiate the Diagnosis of Vestibular Migraine and Meniere’s Disease
*Corresponding author: HesnaBektaş, Associate Professor, Yildirim Beyazit University Medical School, Department of Neurology, Ankara, BilkentYolu 3. Km. Cankaya, 06800 Ankara, Turkey, Tel: 0090- 0312 291 25 25, E-mail id: hesnabek-1@hotmail.com
Pdf Full text